Drugs / Vehicle
Drug research

Vehicle

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Placebo

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisNCT05432596ACRSPhase 2Completed2023-10-26Actual
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia CongenitaNCT05180708PVLAPhase 3Completed2023-06-30Actual
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisNCT04598269ACRSPhase 2Completed2021-04-08Actual
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)NCT07355075Turn TherapeuticsPhase 2, Phase 3Recruiting2027-01-20Estimated
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438Quoin PharmaceuticalsPhase 2, Phase 3Active not recruiting2025-12-30Actual
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT05147233OculisPhase 3Completed2023-06-22Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)NCT06172257OculisPhase 3Completed2026-04-02Actual
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesNCT04081103Glaukos CorporationPhase 2Terminated2022-02-07Actual
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402EPRXPhase 2Completed2023-05-17Actual
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary HyperhidrosisNCT02129660Journey Medical CorporationPhase 2Completed2015-01Actual
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryNCT06128369OculisPhase 3Terminated2024-05-02Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)NCT05066997OculisPhase 2, Phase 3Completed2026-04-10Actual
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)NCT07246590VRCAPhase 3Recruiting2027-06Estimated
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)NCT07443202TARSPhase 2Enrolling by invitation2026-12-31Estimated

Regulatory dates and decisions

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.